COSMOS HEALTH INC.: 10-K filed 2014-04-11
What COSMOS HEALTH INC. reported in its annual report filed 2014-04-11 (fiscal FY 2013): 21 published measures, 38 facts as tagged in accession 0001477932-14-001658.
This filing
- Form
- 10-K (annual report)
- Filed
- 2014-04-11
- Fiscal period
- fiscal FY 2013
- Accession
- 0001477932-14-001658 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All COSMOS HEALTH INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 867,050 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 920,734 | USD | |
| At 2012-12-31 | 1,403 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | -53,684 | USD | |
| At 2012-12-31 | -1,403 | USD | |
| At 2011-12-31 | -917 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 864,489 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 246,592 | USD | 365 |
| 2012-01-01 to 2012-12-31 | -455 | USD | 366 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 831,400 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 31 | USD | 366 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 902,369 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 2,368 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 917 | USD | 366 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 18,148 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 242,004 | USD | |
| At 2012-12-31 | -4,588 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 106,677,543 | shares | 365 |
| 2012-01-01 to 2012-12-31 | 100,000,000 | shares | 366 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 106,744,743 | shares | 365 |
| 2012-01-01 to 2012-12-31 | 100,000,000 | shares | 366 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 0 | USD/shares | 365 |
| 2012-01-01 to 2012-12-31 | 0 | USD/shares | 366 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 0 | USD/shares | 365 |
| 2012-01-01 to 2012-12-31 | 0 | USD/shares | 366 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 39,681 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 288,712 | USD | 365 |
| 2012-01-01 to 2012-12-31 | -455 | USD | 366 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 125,585,532 | shares | |
| At 2012-12-31 | 100,000,000 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | -432,593 | USD | |
| At 2012-12-31 | -95,561 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 11,319 | USD | |
| At 2012-12-31 | -1,254 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 286,273 | USD | 365 |
| 2012-01-01 to 2012-12-31 | -455 | USD | 366 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 56,163 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 455 | USD | 366 |
Inspect the source
- Entity
- COSMOS HEALTH INC. / CIK 0001474167
- Captured
- 2026-09-20T09:07:57.368Z
- SEC response SHA-256
f91884dcfc5ed49a155a49d6e8abdd1a5d8586cbb0334ac226e4561bd32d019e
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001474167.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))